MYELOPROLIFERATIVE NEOPLASM
Clinical trials for MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer relapse prevention drug trial halted early
Disease control TerminatedThis study tested the drug fedratinib as a maintenance treatment after a stem cell transplant in people with myeloproliferative neoplasms (a type of blood cancer). The goal was to see if it could prevent the cancer from returning. Only 12 people took part before the study was sto…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
Promising combo for advanced blood cancer hits snag: trial ends early
Disease control TerminatedThis study looked at combining two drugs, ruxolitinib and CPX-351, to treat advanced stages of myeloproliferative neoplasms (MPN), a group of blood cancers. The goal was to find the best dose and see if the combo worked better than standard care for patients whose disease had pro…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC